FHIR © HL7.org  |  FHIRsmith 4.0.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

ValueSets, Realm US

14,182 resources

Source: Text:

By Version

By Authority

  • none: 1,981
  • hl7: 12,201

 

Start Prev Rows 7200 - 7400 Next

PackageVersionIdentityName/TitleStatusFMMWGDateAuthSource(s)
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.277.jsonToxic Stress Goals SNOMED CTactive2025-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.279.jsonRacism Interventions SNOMED CTactive2025-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.286.jsonToxic Stress Diagnoses SNOMED CTactive2025-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.287.jsonToxic Stress Diagnoses ICD10CMactive2025-07hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.288.jsonToxic Stress Diagnosesactive2025-06hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.290.jsonToxic Stress Interventions SNOMED CTactive2025-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.308.jsonRacism Goals SNOMED CTactive2025-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.309.jsonProtective Factors Findings SNOMED CTactive2025-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.310.jsonProtective Factors Findings ICD10CMactive2025-07hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.311.jsonProtective Factors Findingsactive2025-07hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1247.312.jsonSocial Determinants of Health Programs SNOMED CTactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.266.jsonCT Angiography of Chestactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.408.jsonBladder Cancer Siteactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.409.jsonBladder Cancer Siteactive2025-10hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.410.jsonProstate Anatomical Siteactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.411.jsonProstate Anatomical Siteactive2025-10hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.412.jsonActive Depression Managementactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.413.jsonActive Depression Managementactive2025-10hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.415.jsonFollow Up for Above Normal BMIactive2025-10hl7
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1248.416.jsonFollow Up For Below Normal BMIactive2025-10hl7
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1251.11.jsonCongenital Heart Disease (structural)active2025-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1260.511.jsonCytotoxic Chemotherapiesactive2025-08hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1260.512.jsonBiphosphonate Therapy Not Done Medical Reason SNOMEDCTactive2025-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1260.513.jsonBiphosphonate Therapy Not Done Patient Reason SNOMEDactive2025-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1260.514.jsonNeoplasm of BrainICD9active2025-10hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1260.515.jsonNeoplasmofBrainICD9ICD10active2025-10hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1267.34.jsonPortable Medical Order Categoriesactive2025-10hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.16.jsonSolid Organ Transplant Proceduresactive2025-10hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.17.jsonSolid Organ Transplant Procedures SNOMEDactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.18.jsonSolid Organ Transplant Procedures ICD10PCSactive2025-10hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.20.jsonPruritus Diagnoses ICD10CMactive2025-10hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.21.jsonPruritusactive2025-10hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.22.jsonPruritus Diagnoses SNOMEDactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.23.jsonSolid Organ Transplant Diagnosis Codesactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.24.jsonNeuraxial Anesthesiaactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.25.jsonMethylprednisoloneactive2025-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.26.jsonIntravenous Heparin Administration Routeactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.27.jsonCVC Insertion Procedureactive2025-10hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.28.jsonVascular Surgeries ICD10PCSactive2025-10hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.29.jsonHeparin for VTE Treatmentactive2025-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1272.30.jsonNon Heparin Anticoagulants for VTE Treatmentactive2025-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1280.2.jsonExposure Locationactive2025-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1290.19.jsonTranscranial doppler ultrasonography (TCD) HCPCSactive2025-09hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.267.jsonFamily History of Breast Canceractive2025-09hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.268.jsonFamily History of Breast Canceractive2025-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.269.jsonPatient Declined Or Refused Genetic Testingactive2025-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.270.jsonFamily History of Prostate Canceractive2025-09hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.271.jsonFamily History of Prostate Canceractive2025-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.272.jsonBreast Cancer Maleactive2025-09hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.273.jsonPathological Stageactive2025-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.274.jsonGenetic Counselingactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.275.jsonGenetic Counselingactive2025-10hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.276.jsonMetastatic Canceractive2025-09hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.283.jsonPaclitaxel Injectableactive2025-11hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.284.jsonEpidermal Growth Factor Receptor EGFR Testingactive2025-11hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.285.jsonAnaplastic Lymphoma Kinase ALK Testingactive2025-11hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.286.jsonROS1 Testingactive2025-11hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.287.jsonNeurotrophic Receptor Tyrosine Kinase NTRK Testingactive2025-11hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.288.jsonBRAF Testingactive2025-11hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.289.jsonMET Testingactive2025-11hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.290.jsonRET Gene Testingactive2025-11hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.291.jsonKRAS Mutation Testingactive2025-11hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.292.jsonPD L1 Testingactive2025-11hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.3.293.jsonRadiation Treatment Deliveryactive2025-11hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.250.jsonFamily History of Breast Canceractive2025-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.251.jsonFamily History of Prostate Canceractive2025-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.252.jsonBreast Cancer Maleactive2025-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.253.jsonSecondary Canceractive2025-09hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.254.jsonGenetic Counselingactive2025-10hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.1444.5.258.jsonPlatinum Based Chemotherapy Agentactive2025-11hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1285.jsonUnilateral Mastectomyactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1286.jsonTotal Nephrectomyactive2025-10hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1287.jsonTotal Nephrectomyactive2025-10hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1288.jsonTotal Nephrectomyactive2025-10hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1289.jsonTotal Nephrectomyactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1290.jsonPartial Nephrectomyactive2025-10hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1291.jsonPartial Nephrectomyactive2025-10hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1292.jsonPartial Nephrectomyactive2025-10hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.1293.jsonPartial Nephrectomyactive2025-10hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1348.jsonInfluenza Immunization Administeredactive2025-10hl7cvx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1926.jsonACE Inhibitor or ARB or ARNI Ingredientactive2023-02hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.1927.jsonPsych Visit Psychotherapyactive2017-05hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.213.jsonProstate Cancer Treatmentactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.215.jsonProstate Specific Antigen Testactive2024-02hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.23.jsonHeart Failureactive2017-05hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.24.jsonHeart Failureactive2019-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.242.jsonPregnancyactive2024-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.243.jsonPregnancyactive2016-03hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.25.jsonHeart Failureactive2023-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.264.jsonAtrioventricular Blockactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.3000.jsonMetforminactive2019-12hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.303.jsonCardiac Paceractive2023-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.305.jsonPatient Reason for ACE Inhibitor or ARB Declineactive2017-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.311.jsonPatient Reasonactive2025-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.313.jsonMedical Reasonactive2022-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.323.jsonSalvage Therapyactive2017-05hl7cpt
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.324.jsonSalvage Therapyactive2017-05hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.325.jsonPain Warranting Further Investigation for Prostate Canceractive2023-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.39.jsonACE Inhibitor or ARB or ARNIactive2022-02hl7rx
fhir.nwgenomics.nhs.ukR4ValueSet-admission-source.jsonAdmission Sourcedraft2026-02hl7
fhir.kenyaCoreIGR4ValueSet-location-type-vs.jsonLocation Type Value Setdraft2026-01hl7internal
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1222.140.jsonFerritinactive2024-07hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.113.12.1005.jsonRheumatoid Arthritisactive2024-01hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.113.11.1080.jsonRheumatoid Arthritisactive2021-02hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.464.1003.113.11.1081.jsonRheumatoid Arthritisactive2022-02hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1222.1428.jsonMyalgiaactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1222.1439.jsonVomitingactive2024-07hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1222.1525.jsonCognitive disorder Diagnosis ICD10active2024-06hl7icd
hl7.fhir.us.ccdaR4ValueSet-2.16.840.1.113883.11.20.4.1.jsonDischargeSummaryDocumentTypeCodetrial-usecgp2025-07hl7loinc
hl7.fhir.us.ccdaR4ValueSet-2.16.840.1.113883.1.11.20.22.jsonHPDocumentTypetrial-usecgp2025-07hl7loinc
hl7.fhir.us.ccdaR4ValueSet-2.16.840.1.113762.1.4.1099.10.jsonCare Plan Document Typetrial-usecgp2025-07hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1139.jsonS4G Hyperlipidemiaactive2022-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1291.jsonS4G Cardiomyopathyactive2022-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1292.jsonS4G Tricuspid valve disorderactive2022-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1293.jsonS4G Pompe diseaseactive2022-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1294.jsonS4G Malignant hyperthermiaactive2022-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1295.jsonS4G Malignancyactive2022-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1297.jsonS4G Intestinal polypactive2022-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1298.jsonS4G Hamartomaactive2022-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1299.jsonS4G Diabetes mellitusactive2022-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1300.jsonS4G Muscular dystrophy and weaknessactive2022-08hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1325.jsonS4G Hamartoma and S4G Intestinal Polypactive2022-08hl7vsac
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1196.1326.jsonS4G Malignancy and S4G Intestinal Polypactive2022-08hl7vsac
hl7.fhir.us.registry-protocolsR4ValueSet-SmokingStatus.jsonSmoking Statusactivecic2023-11hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.526.2.168.jsonCardiac Surgeryactive2025-02hl7sct
fhir.nwgenomics.nhs.ukR4ValueSet-document-entry-type.jsonDocumentEntry Typedraft2026-02hl7sct
fhir.nwgenomics.nhs.ukR4ValueSet-GenomicCancer.jsonGenomic Cancer Test Directorydraft2026-02hl7
fhir.nwgenomics.nhs.ukR4ValueSet-GenomicRareAndInheritedDisease.jsonGenomic Rare and Inherited Disease Test Directorydraft2026-02hl7
fhir.nwgenomics.nhs.ukR4ValueSet-GenomicTestCodes.jsonGenomic Test Codesdraft2026-02hl7
fhir.nwgenomics.nhs.ukR4ValueSet-specimen-tracking-events.jsonSpecimen Tracking Eventsdraft2026-02hl7tho
fhir.nwgenomics.nhs.ukR4ValueSet-document-entry-class.jsonDocumentEntry Classdraft2026-02hl7sct
fhir.nwgenomics.nhs.ukR4ValueSet-document-entry-mimetype.jsonDocumentEntry mimeTypedraft2026-02hl7ietf
us.nlm.vsacR4ValueSet-2.16.840.1.113883.3.666.5.1668.jsonCABG Surgeriesactive2022-02hl7cms
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1099.10.jsonCare Plan Document Typeactive2024-10hl7loinc
fhir.nwgenomics.nhs.ukR4ValueSet-GenomicClinicalIndicationCodes.jsonGenomic Clinical Indication Codesdraft2026-02hl7internal
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1021.30.jsonAdministrationUnitDoseFormactive2024-06hl7ncit
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7185.jsonIndustry CDC Census 2002active2013-01oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7184.jsonOccupation CDC Census 2002active2013-01oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.8028.jsonOccupation CDC SOC 2010active2021-01tho oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7187.jsonIndustry CDC Census 2010active2013-01tho
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7186.jsonOccupation CDC Census 2010active2013-01tho
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.8027.jsonIndustry CDC Census 2012active2021-01oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.8025.jsonIndustry CDC NAICS 2012active2021-01oid
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.8026.jsonOccupation CDC Census 2012active2021-01oid
us.nlm.vsacR4ValueSet-1.3.6.1.4.1.12009.10.2.5.jsonLOINC Imaging Document Codesactive2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.11.20.8.1.jsonProgressNoteDocumentTypeCodeactive2024-07hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1186.5.jsonCommon refutations for substance causes for allergy and intolerance documentationactive2024-06hl7sct
us.nlm.vsacR4ValueSet-2.16.840.1.113883.11.20.1.1.jsonSurgicalOperationNoteDocumentTypeCodeactive2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113883.1.11.20.2.3.jsonReferralDocumentTypeactive2024-06hl7loinc
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.93.jsonAlbuminuria I10active2023-09hl7icd
us.nlm.vsacR4ValueSet-2.16.840.1.113762.1.4.1078.189.jsonSGLT2iactive2023-10hl7rx
us.nlm.vsacR4ValueSet-2.16.840.1.114222.4.11.3591.jsonPayer Typeactive2025-04hl7
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7162.jsonCountry (GEC)active2018-12oid
ca.on.dhdr.r4.v4R4DIN.jsonDrug Identification Number-DINactive2022-03hl7fhir
fhir.cdc.opioid-cds-r4R4ValueSet-pain-treatment-plan.jsonPain treatment planactive2023-05hl7loinc
signal.core.r4R4valueset-questionnaire-ccars-school-development.jsonQuestionnaire CCARS School Developmentdraft1pahl7
signal.core.r4R4valueset-questionnaire-ccars-school-problems.jsonQuestionnaire CCARS School Problemsdraft1pahl7
us.cdc.phinvadsR4ValueSet-2.16.840.1.113883.1.11.19563.jsonPersonal Relationship Role Type Value Setactive2013-12tho
us.nlm.vsacR4ValueSet-2.16.840.1.113883.1.11.19563.jsonPersonal Relationship Role Typeactive2024-06hl7tho
fhir.r4.wales.testR4ValueSet-DataStandardsWales-Occupation.jsonData Standards Wales Occupationdraft2023-05hl7sct
fhir.r4.wales.testR4ValueSet-DataStandardsWales-Religion.jsonData Standards Wales Religionactive2023-08hl7sct
us.cdc.phinvadsR4ValueSet-2.16.840.1.113883.11.20.9.21.jsonAgePQ_UCUMactive2016-01ucum
fhir.r4.nhsengland.programmeR4ValueSet-England-ConsentStatusReason.jsonEngland Consent Status Reasondraft2025-09hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-FlagCodeProgramme.jsonEngland Flag Code Programmedraft2024-02hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-FlagCodeRA.jsonEngland Flag Code RAdraft2024-02hl7
us.nlm.vsacR4ValueSet-2.16.840.1.113883.11.20.9.22.jsonProcedureAct statusCodeactive2024-06hl7tho
fhir.r4.nhsengland.programmeR4ValueSet-England-FlagConditionCode.jsonEngland Flag Condition Codedraft2024-02hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-FlagConditionCategory.jsonEngland Flag Condition Categorydraft2024-02hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-FlagCategoryProgramme.jsonEngland Flag Category Programmedraft2024-02hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-FlagProvenanceRole.jsonEngland Flag Provenance Roledraft2024-06hl7tho dcm
fhir.r4.nhsengland.stu1R4nhsdigital-message-events.jsonNHSMessageEventsdrafthl7
fhir.r4.nhsengland.stu1R4ValueSet-England-PeriodType.jsonEngland Period Typeactive2025-06hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-ScreeningEpisodeTypeCode.jsonEngland Screening Episode Type Codedraft2024-11hl7
fhir.r4.wales.psomR4ValueSet-DataStandardsWales-PSOM-MessageEvent.jsonData Standards Wales PSOM Message Eventdrafthl7
fhir.r4.wales.psomR4ValueSet-DataStandardsWales-PSOM-Language.jsonData Standards Wales PSOM Languagedrafthl7tho
fhir.r4.wales.psomR4ValueSet-DataStandardsWales-PSOM-PROMsLaterality.jsonData Standards Wales PSOM PROMs Lateralitydrafthl7
fhir.r4.wales.psomR4ValueSet-DataStandardsWales-PSOM-PathwayLaterality.jsonData Standards Wales PSOM Pathway Lateralitydrafthl7
fhir.r4.wales.psomR4ValueSet-DataStandardsWales-PSOM-PathwayType.jsonData Standards Wales PSOM Pathway Typedrafthl7
fhir.r4.wales.psomR4ValueSet-DataStandardsWales-PSOM-TriggerEventType.jsonData Standards Wales PSOM Trigger EventTypedrafthl7
fhir.r4.nhsengland.programmeR4ValueSet-England-EndpointConnectionType.jsonEngland Endpoint Connection Typedraft2025-08hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-HigherRiskGeneCode.jsonEngland Higher Risk Gene Codedraft2024-11hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-ScreeningCeased.jsonEngland Screening Ceaseddraft2024-11hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-NTDDCalculationMethodScreening.jsonEngland NTDD Calculation Method Screeningdraft2024-11hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-CategoryFlagScreening.jsonEngland Category Flag Screeningdraft2024-11hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-EndCodeScreening.jsonEngland End Code Screeningdraft2024-11hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-ScreeningSourceOfServiceRequest.jsonEngland Screening Source Of Service Requestdraft2024-11hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-HighRiskReferralReasonScreening.jsonEngland High Risk Referral Reason Screeningdraft2024-11hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-RemovalReasonScreening.jsonEngland Removal Reason Screeningdraft2024-11hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-NHSIdentityProofingLevel.jsonEngland NHS Identity Proofing Leveldraft2025-09hl7
fhir.r4.nhsengland.programmeR4ValueSet-England-EpisodeFinalActionCode.jsonEngland Episode Final Action Codedraft2024-11hl7
hl7.fhir.us.mcodeR4ValueSet-mcode-cancer-disorder-vs.jsonCancer Disorder Value Setactive4cic2025-02hl7fhir
hl7.fhir.us.pq-cmc-fdaR5ValueSet-pqcmc-release-mechanism.jsonRelease Mechanism Terminologytrial-use2brr2025-07hl7ncit
hl7.fhir.us.pq-cmc-fdaR5ValueSet-pqcmc-release-profile.jsonRelease Profile Terminologytrial-use2brr2025-07hl7ncit
hl7.fhir.us.pq-cmc-fdaR5ValueSet-capsule-classification-category.jsonCapsule Shell Classification Terminologytrial-use2brr2025-07hl7ncit
hl7.fhir.us.pq-cmc-fdaR5ValueSet-pqcmc-coating-purpose.jsonCoating Purpose Terminologytrial-use2brr2025-07hl7ncit
hl7.fhir.us.pq-cmc-fdaR5ValueSet-pqcmc-product-part-ingredient-physical-location.jsonIngredient Location Terminologytrial-use2brr2025-07hl7ncit
hl7.fhir.us.pq-cmc-fdaR5ValueSet-pqcmc-product-part-type.jsonProduct Part Type Terminologytrial-use2brr2025-07hl7ncit
hl7.fhir.us.pq-cmc-fdaR5ValueSet-pqcmc-substance-name-type.jsonSubstance Name Typetrial-use2brr2025-07hl7ncit
us.cdc.phinvadsR4ValueSet-2.16.840.1.114222.4.11.7597.jsonWork Classification (ODH)active2020-01tho
fhir.outburn.co.ilR4ValueSet-vs-clinical-findings-detection.jsonDetected and Not-detected modifiersdrafthl7sct